Director, Clinical Imaging, Translational Sciences-Immunology

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.  We provide an inclusive work environment where each person is considered as an individual.  At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Discovery & Pre-Clinical/Clinical Development

Job Sub Function:

Translational Discovery & Development Biomarkers

Job Category:

Scientific/Technology

All Job Posting Locations:

Spring House, Pennsylvania, United States of America

Job Description:

About Innovative Medicine

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

About Immunology

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Our Immunology team leads in the development of transformational medicines for immunological disorders and illnesses. You can influence where medicine is going by restoring health to millions of people living with immune diseases. 

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

We are searching for the best talent for a Director, Clinical Imaging-Translational Science- Immunology, to be in Spring House, PA or Cambridge, MA.

 

The Director, Clinical Imaging will provide strategic and scientific leadership for the development, validation, and delivery of imaging-derived endpoints to enable high-impact decision-making across the Immunology portfolio, with a primary focus on Gastrointestinal (GI) diseases. The role is US-based (Spring House, PA or Cambridge) and sits within the Translational Science organization, operating in a highly matrixed environment across Immunology Disease Area Strategy, Clinical Development, Data Sciences, Regulatory, and operational functions. This position is intentionally scoped and graded to ensure imaging and digital capabilities are positioned as strategic assets for Immunology, driving endpoint innovation for precision medicine from early to late phase. The Director will balance innovation, platform building, and technical delivery, ensuring that advanced measurement approaches are translated into fit-for-purpose, scalable solutions that support portfolio objectives.

Key Responsibilities:

Scientific & Strategic Technology Leadership

• Lead the GI-focused imaging measurement strategy across Immunology assets, spanning early through late-phase clinical development.
• Shape endpoint strategies integrating imaging measurements to support mechanistic understanding, proof-of-concept, and decision-enabling outcomes including regulatory.
• Partner with Disease Area Strategy and Translational Science leaders to ensure alignment with portfolio priorities and clinical development plans.
• Contribute to investment cases, governance discussions, and portfolio reviews, articulating value, readiness, and risk.

Clinical Trial Delivery & Execution

• Provide scientific oversight and accountability for imaging endpoints across early- and late-phase clinical trials.
• Ensure methods have an operationally delivery model to scale.
• Partner with clinical and operational partners a